当前位置: 首页 > 期刊 > 《新医学》 > 202011
编号:13794272
后腹膜卵黄囊瘤一例(3)
http://www.100md.com 2020年11月1日 《新医学》 202011
     [4] Wang Y, Yang J, Yu M, Cao D, Zhang Y, Zong X, Shen K. Ovarian yolk sac tumor in postmenopausal females: a case series and a literature review. Medicine (Baltimore), 2018, 97(33): e11838.

    [5] 肖学红.20例卵黄囊瘤的CT和MRI诊断. 广东医学院学报, 2016, 34(5):494-497.

    [6] 迟源, 马羽佳, 郑加贺, 刘兆玉. 卵黄囊瘤的CT及MRI表现. 现代肿瘤医学, 2016, 24(8): 1278-1283.

    [7] 徐炼, 王巍, 何英, 王梅, 黄芹, 刘娟, 吴秀丽. 卵巢卵黄囊瘤46例临床病理分析. 四川大学学报(医学版), 2018, 49(4):680-682.

    [8] Nasioudis D, Frey MK, Chapman-Davis E, Caputo TA, Holcomb K. Fertility-preserving surgery for advanced stage ovarian germ cell tumors. Gynecol Oncol, 2017, 147(3):493-496.

    [9] Turkmen O, Karalok A, Basaran D, Kimyon GC, Tasci T, Ureyen I, Tulunay G, Turan T. Fertility-sparing surgery should be the standard treatment in patients with malignant ovarian germ cell tumors. J Adolesc Young Adult Oncol, 2017, 6(2):270-276.

    [10] Zhang GY, Zhang R, Wu LY, Li B, Li SM. Neoadjuvant bleomycin, etoposide, and cisplatin (BEP) chemotherapy in the treatment of extensively advanced yolk sac tumors: a single center experience. Int J Gynecol Cancer, 2018, 28(4):713-720.

    (收稿日期:2020-05-26)

    (本文編辑:林燕薇), 百拇医药(熊茜?古健)
上一页1 2 3